Findings

What do systematic reviews say?

1 questions · 1 findings · 1 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 1 · 100%

Gynaecological toxicity · women with hormone‐sensitive advanced breast cancer

Fulvestrant showed no clear difference in gynaecological toxicity compared with other endocrine treatment (high certainty).

1 finding from 1 review

Fulvestrant for hormone‐sensitive metastatic breast cancer 2017 · Cochrane Headline outcomes only
RR 1.22 [0.94, 1.57]
6 studies · 2848 participants
High